NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/17/2026
Back to search
Official data from USPTO
PGI PSYCHOGENICS TRANSFORMING CNS DISCOVERY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
02/17/2026
Trademark type
Combined
Nice classes
42
Filing date
11/20/2024
Registration date
02/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/17/2026
Last transaction
02/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
11/11/2023
First use in commerce
11/11/2023
Drawing code
5
Owner type
03
Owner location
Paramus, NJ
Examiner
DWYER, JOHN D
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized letters "P", "G" and "I" combined together which appears to the left of the stylized mark "PsychoGenics." The phrase "Transforming CNS Discovery" appears below.
Holders and representatives
Holders
PsychoGenics Inc.
Representatives
Lynn E. Rzonca
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research in the field of behavioralanalgesicpsychiatricneuroprotectivecircadiancognitive and motor capacities on normalmutateddrug-treated or aged animals; medical research testing in the field of preclinical research; medical research testing in the field of drug discovery research; medical research testing in the field of central nervous system research; pharmacological phenotype testing in the field of drug discovery and medical research; scientific research and development services in the field of drug discoverypsychiatrythe central nervous systemutilizing apparatus for measuring and accessing motor responses on normaldrug-treated or aged animals; medical and scientific researchpharmaceutical and biotechnological research of human disorders using animal modelsspecificallyscreening and testing of chemical compounds for therapeutic or toxic effectscapturingquantifyingprocessing and electronic data storage of information on behavioral and physiological changes in animal subjects
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/17/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/30/2025
PUBO
PUBLISHED FOR OPPOSITION
12/30/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/24/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/03/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
12/03/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/03/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
12/03/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/03/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/14/2025
GNFR
FINAL REFUSAL E-MAILED
09/14/2025
CNFR
FINAL REFUSAL WRITTEN
09/14/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/20/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/20/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/20/2025
GNRT
NON-FINAL ACTION E-MAILED
05/20/2025
CNRT
NON-FINAL ACTION WRITTEN
05/20/2025
DOCK
ASSIGNED TO EXAMINER
05/14/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2025
NWAP
NEW APPLICATION ENTERED
11/20/2024
Continuous trademark protection
Get notified about every new filing that threatens PGI PSYCHOGENICS TRANSFORMING CNS DISCOVERY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.